Ten key points about COVID-19 in children: The shadows on the wall

Luis Escosa-García1, David Aguilera-Alonso2, Cristina Calvo1

  • 1Department of Pediatrics, Infectious, and Tropical Diseases, La Paz Hospital, The Translational Research Network of Pediatric Infectious Diseases (RITIP), Madrid, Spain.

Pediatric Pulmonology
|August 14, 2020
PubMed

Insights

Children generally experience mild COVID-19 illness, but their role in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission is critical for public health strategies. Understanding pediatric COVID-19 is essential.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • The COVID-19 pandemic, caused by SARS-CoV-2, presents unique challenges in understanding its impact on pediatric populations.
  • Most existing literature on COVID-19 focuses on adult patients, leaving a knowledge gap regarding disease characteristics in children.

Purpose of the Study:

  • To review and summarize the current literature on COVID-19 in children.
  • To identify key characteristics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pediatric patients.

Main Methods:

  • Expert review of peer-reviewed and preprint studies published between January 1, 2020, and May 28, 2020.
  • Inclusion of relevant articles published after the specified period.

Main Results:

  • Pediatric COVID-19 cases typically present with mild illness.
  • Children appear to have a lower risk of severe complications and mortality compared to adults.
  • The role of children in the transmission dynamics of SARS-CoV-2 requires further definition.

Conclusions:

  • Children are generally less severely affected by COVID-19 but their transmission potential is a key factor in epidemiological models.
  • Further research is needed to fully elucidate the impact of COVID-19 on children and their role in pandemic spread.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
147
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.3K
Controls in Experiments01:13

Controls in Experiments

When conducting an experiment, it is crucial to have control to reduce bias and accurately measure the dependent variables. It also marks the results more reliable. Controls are elements in an experiment that have the same characteristics as the treatment groups but are not affected by the independent variable. By sorting these data into control and experimental conditions, the relationship between the dependent and independent variables can be drawn. A randomized experiment always includes a...
14.6K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
174
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131